Drug recall D-1027-2022
Product
Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06
Reason for recall
cGMP deviations: Temperature abuse
Lots and codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Recall details
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Quantity
- 29 boxes
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 13, 2022
- Terminated
- November 30, 2023
Related products
- Aprepitant – drug information
- NDC 0781-4063 Aprepitant · · Sandoz Inc
- NDC 0781-2321 Aprepitant · Aprepitant 40 mg/1 · Sandoz Inc
- NDC 0781-2322 Aprepitant · Aprepitant 80 mg/1 · Sandoz Inc
- NDC 0781-2323 Aprepitant · Aprepitant 125 mg/1 · Sandoz Inc